Jennifer McNealey
Director/Board Member chez ANTIBE THERAPEUTICS INC.
Fortune : 12 842 $ au 31/03/2024
Profil
Jennifer Isacoff McNealey is the founder of Laurient LLC, which was founded in 2005.
She is currently an Independent Director at Antibe Therapeutics, Inc. and Conduit Pharmaceuticals, Inc. She is also the Chief Financial Officer at Abdera Therapeutics, Inc. Jennifer's former jobs include being an Independent Director at Enzon Pharmaceuticals, Inc. from 2013 to 2021, Senior Director-Investor Relations at Calithera Biosciences, Inc. from 2015 to 2016, Analyst at Amerindo Investment Advisors, Inc., Portfolio Manager at Paramount Capital, Inc., Analyst at Franklin Advisers, Inc., Research Analyst at Weiss, Peck & Greer LLC, and Portfolio Manager at Morgan Stanley Dean Witter Advisors, Inc. She was also the Chief Financial Officer at Telesis Bio, Inc. from 2015 to 2022.
Jennifer received her undergraduate and graduate degrees from Cornell University in 1995 and 1997, respectively.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/01/2024 | 38 334 ( 0,07% ) | 12 842 $ | 31/03/2024 |
Postes actifs de Jennifer McNealey
| Sociétés | Poste | Début |
|---|---|---|
| ANTIBE THERAPEUTICS INC. | Director/Board Member | 24/11/2020 |
| CONDUIT PHARMACEUTICALS INC. | Director/Board Member | 22/09/2023 |
Abdera Therapeutics, Inc.
 Abdera Therapeutics, Inc. BiotechnologyHealth Technology Abdera Therapeutics, Inc. is a Canadian precision oncology company that operates in the field of cancer treatment. The CEO of the company is Lana Elizabeth Janes. | Director of Finance/CFO | - |
Anciens postes connus de Jennifer McNealey
| Sociétés | Poste | Fin |
|---|---|---|
| TELESIS BIO, INC. | Director of Finance/CFO | 08/07/2022 |
| ENZON PHARMACEUTICALS, INC. | Director/Board Member | 01/11/2021 |
| Laurient LLC | Founder | 01/01/2012 |
Franklin Advisers, Inc.
 Franklin Advisers, Inc. Investment ManagersFinance Franklin Advisers, Inc. is a mutual fund manager and registered investment advisor headquartered in San Mateo, California. The firm was founded in 1985 and is a subsidiary of Franklin Resources, Inc. (NYSE: BEN), a holding company that, together with its various subsidiaries is referred to as Franklin Templeton Investments. Franklin Advisers provides investment advisory and portfolio management services to US and non-US, registered open-end and closed-end funds and unregistered funds, as well as separate accounts. | Analyst-Equity | 01/08/2005 |
| Morgan Stanley Dean Witter Advisors, Inc. | Corporate Officer/Principal | - |
Formation de Jennifer McNealey
| Cornell University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| ENZON PHARMACEUTICALS, INC. | Health Technology |
| CALITHERA BIOSCIENCES, INC. | Health Technology |
| ANTIBE THERAPEUTICS INC. | Health Technology |
| TELESIS BIO, INC. | Commercial Services |
| CONDUIT PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Amerindo Investment Advisors, Inc.
 Amerindo Investment Advisors, Inc. Investment ManagersFinance Amerindo Investment Advisors Inc. is a San Francisco-based firm that manages institutional portfolios having a focus on Internet and Internet related issuers. The firm's separate account business consists of corporate ERISA plans, public pension plans, endowments, foundations, family trusts and high net worth individuals. Amerindo mutual funds are offered for the investor seeking a concentration in emerging technology with a focus on the Internet, health sciences and biotechnology. | Finance |
| Paramount Capital, Inc. | |
Franklin Advisers, Inc.
Franklin Advisers, Inc. Investment ManagersFinance Franklin Advisers, Inc. is a mutual fund manager and registered investment advisor headquartered in San Mateo, California. The firm was founded in 1985 and is a subsidiary of Franklin Resources, Inc. (NYSE: BEN), a holding company that, together with its various subsidiaries is referred to as Franklin Templeton Investments. Franklin Advisers provides investment advisory and portfolio management services to US and non-US, registered open-end and closed-end funds and unregistered funds, as well as separate accounts. | Finance |
| Weiss, Peck & Greer LLC | Finance |
| Morgan Stanley Dean Witter Advisors, Inc. | |
| Laurient LLC | |
Abdera Therapeutics, Inc.
Abdera Therapeutics, Inc. BiotechnologyHealth Technology Abdera Therapeutics, Inc. is a Canadian precision oncology company that operates in the field of cancer treatment. The CEO of the company is Lana Elizabeth Janes. | Health Technology |
